David N. Louis
Harvard University
3 papers in the Anchorcite directory, published between 2004 and 2021, cited 40,367 times in total.
ORCID profileResearch topics
- Glioma Diagnosis and Treatment · 2 papers
- Meningioma and schwannoma management · 2 papers
- Tuberous Sclerosis Complex Research · 1 paper
- Cancer Genomics and Diagnostics · 1 paper
- HER2/EGFR in Cancer Research · 1 paper
- Lung Cancer Treatments and Mutations · 1 paper
Frequent co-authors
- Hiroko Ohgaki · 1 paper
- Anne Jouvet · 1 paper
- Bernd Walter Scheithauer · 1 paper
- Arie Perry · 1 paper
- Pieter Wesseling · 1 paper
- Daniel Jay Brat · 1 paper
- Ian A. Cree · 1 paper
- Dominique Figarella‐Branger · 1 paper
Papers
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica · 2007 · 15,675 citations
The fourth edition of the World Health Organization (WHO) classification of tumours of the central nervous system, published in 2007, lists several new entities, including angiocentric glioma, papillary glioneuronal tumour, rosette-forming glioneuronal tumour of the fourth ventricle, papillary tumour of…
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryNeuro-Oncology · 2021 · 13,127 citations
The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, is the sixth version of the international standard for the classification of brain and spinal cord tumors. Building on the 2016 updated…
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine · 2004 · 11,565 citations
BACKGROUND: Most patients with non-small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor receptor (EGFR). However, about 10 percent of patients have a rapid and often dramatic clinical response. The molecular…
Metadata from OpenAlex (CC0).